Recommended Diazepam Dose for Acute Seizure Management
For status epilepticus in adults, administer diazepam 5-10 mg IV initially, repeated every 10-15 minutes as needed up to a maximum of 30 mg. 1
Adult Dosing Algorithm
Intravenous Route (Preferred)
- Initial dose: 5-10 mg IV, administered slowly over approximately 2 minutes 2
- Repeat dosing: May repeat every 10-15 minutes if seizures persist 1
- Maximum total dose: 30 mg 1
- Administration rate: At least 1 minute per 5 mg (1 mL) given 1
Alternative Routes When IV Access Unavailable
- Rectal: 0.5 mg/kg up to 20 mg (though absorption may be erratic) 2
- Intramuscular: NOT recommended due to tissue necrosis risk; other benzodiazepines (lorazepam, midazolam) preferred for IM route 2
Pediatric Dosing
Status Epilepticus
- Infants >30 days and children <5 years: 0.2-0.5 mg slowly every 2-5 minutes, maximum 5 mg total (IV preferred) 1
- Children ≥5 years: 1 mg every 2-5 minutes, maximum 10 mg total (slow IV administration preferred) 1
- Repeat in 2-4 hours if necessary 1
General Pediatric Seizure Management
Critical Safety Considerations
Respiratory monitoring is mandatory. Diazepam significantly increases apnea risk, especially when:
- Given rapidly IV 2
- Combined with other sedative agents 2
- Used in patients with chronic lung disease or unstable cardiovascular status 1
Be prepared to provide respiratory support regardless of administration route. 2
Important Clinical Caveats
Short Duration of Action
Diazepam must be followed immediately by a long-acting anticonvulsant (phenytoin/fosphenytoin) because it redistributes rapidly and seizures often recur within 15-20 minutes. 2 Lorazepam may be preferred as it has prolonged anticonvulsant activity. 2
Administration Technique
- Use large veins; avoid dorsum of hand or wrist 1
- Extreme care to avoid intra-arterial administration or extravasation 1
- Do NOT mix or dilute with other solutions in syringe or infusion container 1
Dose Adjustments
Lower doses (2-5 mg) and slow titration should be used for:
Contemporary Context
While diazepam remains FDA-approved and guideline-supported for status epilepticus, current evidence suggests lorazepam, levetiracetam, or valproate may be preferred as first-line benzodiazepines for refractory status epilepticus after initial benzodiazepine failure. 3, 4 The 2024 ACEP guidelines recommend fosphenytoin, levetiracetam, or valproate as second-line agents with similar efficacy after benzodiazepine failure. 3